{"id":"W4220879423","doi":"10.1016/j.jtho.2022.02.011","title":"Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Loxo Oncology; Sanofi Genzyme; Takeda Oncology; EMD Serono; Genentech; National Institutes of Health; Astellas Pharma; Daiichi-Sankyo; Damon Runyon Cancer Research Foundation; Revolution Medicines; American Cancer Society; Society for Immunotherapy of Cancer; Boehringer Ingelheim; AbbVie; Massachusetts Institute of Technology; Takeda Pharmaceutical Company; Broad Institute; Sanofi; GlaxoSmithKline; Spectrum Pharmaceuticals; Merck; AstraZeneca; Canadian Asian Studies Association; Daiichi Sankyo Europe; National Cancer Institute; Foghorn Therapeutics; Bristol-Myers Squibb; Ignyta; Eli Lilly and Company; American Society of Clinical Oncology; Dana-Farber Cancer Institute; Pfizer; Conquer Cancer Foundation","keywords":"Medicine; Mutant; Adenocarcinoma; Mutation; Cancer research; Resistance (ecology); Lung; Oncology; Internal medicine; Genetics; Cancer; Gene; Biology; Ecology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002317679,0.0001694684,0.0002316572,0.0003902081,0.0002563728,0.0006291952,0.0001964889,0.0005222281,0.00471396],"category_scores_gemma":[0.001107868,0.0001590781,0.0002925369,0.000284042,0.000193555,0.0004089764,0.0003052904,0.0004261244,0.0004539002],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003277867,"about_ca_system_score_gemma":0.0002553896,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006584115,"about_ca_topic_score_gemma":0.0009583014,"domain_scores_codex":[0.9997578,0.00004329787,0.0000225666,0.00003989098,0.00006682355,0.00006960297],"domain_scores_gemma":[0.9996451,0.00008745081,0.0001241201,0.00003100473,0.00003539886,0.00007684107],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002888282,0.0006276568,0.3549547,0.00008818709,0.0001579038,0.008818028,0.000205638,0.001179694,0.5758246,0.001497324,0.0008683052,0.05288982],"study_design_scores_gemma":[0.00009674328,0.001937386,0.8830277,0.00003060265,0.0001700571,0.02842893,0.0005223191,0.004332972,0.07595596,0.0009186803,0.004549227,0.00002931129],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984565,0.0002959652,0.0001063702,0.00005944903,0.000006160454,0.000005220437,0.00003034199,0.000009754875,0.001030134],"genre_scores_gemma":[0.9996147,0.0000660851,0.00006063622,0.0000158736,0.000003586075,0.000001179878,0.00002426604,0.000002575667,0.0002111014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00471396,"threshold_uncertainty_score":0.01576972,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02766883821257422,"score_gpt":0.4252409717940304,"score_spread":0.3975721335814562,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}